Protease inhibitors
US6534498B1 · kind B1 · utility
2Cited by
28References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 2002 |
| Grant date | Mar 18, 2003 |
| Priority date | — |
| Expiry date | May 6, 2022 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the compound of Formula (I) or a pharmaceutically acceptable salt, hydrate or solvate thereof, which is an inhibitor of cysteine proteases, particularly cathepsin K, and is useful in the treatment of diseases in which inhibition of bone loss or of cartilage degradation is a factor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.